Author:
Wang Jia,Tang Hao,Wang Xiaokun,Wu Jiarong,Gao Jiaqi,Diao Shuang,Wu Yun
Abstract
Abstract
Background
The Triglyceride and Glucose (TyG) index has been found to have a strong correlation with the recurrence of acute ischemic stroke (AIS) and poor patient outcomes. Nevertheless, the relationship between the TyG index and early neurological deterioration (END) has not been fully explored. Therefore, the present study aims to investigate the potential association between the TyG index and END.
Methods
A retrospective analysis of 2129 patients diagnosed with AIS between January 2019 and December 2022 at the Second Affiliated Hospital of Harbin Medical University. Patients were divided into END and non-END groups based on changes in National Institutes of Health Stroke Scale scores within 7 days of admission, and the differences in the indicators between the two groups were examined using univariate analysis. The patients were then divided into three groups based on the tertile of the TyG index (T1: TyG index < 8.662; T2: 8.662 ≤ TyG index < 9.401; T3: TyG index ≥ 9.401), and logistic regression analysis was used to examine the association between the TyG index and END. Finally, the predictive ability of the TyG index was evaluated using the receiver operating characteristic (ROC) curve.
Results
A total of 724 patients experienced END. The results of the analysis showed that the TyG index was significantly higher in the END group compared to the non-END group. Furthermore, the TyG index was found to be an independent risk factor for the development of END (OR, 1.561; 95% 1.166–2.090, P = 0.003). After adjusting for confounders, the risk of END was 3.953 (95% CI 2.793–5.595; P < 0.001) and 5.906 (95% CI 3.676–9.488; P < 0.001) times higher in the T2 and T3 groups, respectively, in contrast to the T1 group. The area under the ROC curve of the TyG index was 0.711 (0.688–0.733), indicating an excellent predictive indicator.
Conclusions
Our study uncovered that higher TyG index levels were associated with END development in AIS patients.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference32 articles.
1. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England) 2017, 390(10100):1151–1210.
2. Paul S, Candelario-Jalil E: Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies. Experimental neurology 2021, 335:113518.
3. Sabir Rashid A, Huang-Link Y, Johnsson M, Wetterhäll S, Gauffin H: Predictors of Early Neurological Deterioration and Functional Outcome in Acute Ischemic Stroke: The Importance of Large Artery Disease, Hyperglycemia and Inflammatory Blood Biomarkers. Neuropsychiatric disease and treatment 2022, 18:1993–2002.
4. Zhang YB, Su YY, He YB, Liu YF, Liu G, Fan LL. Early neurological deterioration after recanalization treatment in patients with Acute ischemic stroke: a retrospective study. Chin Med J. 2018;131(2):137–43.
5. Lebovitz HE: Insulin resistance: definition and consequences. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association 2001, 109 Suppl 2:S135-148.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献